Christie Hospital (UK), based in Manchester, is one of the top three cancer centres in Europe, with 2,500 staff, 300 volunteers and 30,000 members of staff, treating over 44,000 patients each year. It is also the first comprehensive cancer centre in the UK to be officially accredited. As an NHS-affiliated hospital, Christie's UK offers services such as
Radiotherapy
With one of the world's leading radiotherapy departments, in 2015 Christie Hospital became the UK's first centre for high energy proton beam therapy. The specialist and consultant teams at Christie Hospital have gained extensive experience in building, equipping and commissioning proton beam therapy services.
Chemotherapy
The largest chemotherapy site in the UK, with 10 other chemotherapy sites forming a mobile chemotherapy site for patients to have chemotherapy at home.
Surgery
Capable of performing specialist surgery for complex and rare cancers.
For over 100 years, Christie Hospital has been committed to achieving world class breakthroughs. Christie Hospital has one of the largest trial programmes in the UK, with over 550 ongoing clinical trials. Christie Hospital has been awarded one of the best hospitals in the UK by the National Institute for Health Research (NIHR) for providing patient participation in clinical research.
Christie Hospital has been a leader in breast cancer drug trials, having conducted the world's first clinical trial of the breast cancer drug hexestrol in 1944 and being the first hospital to introduce tamoxifen into the clinic in 1970. The drug is still in use today and millions of women have benefited from it.
In 1986, Christie Hospital was the first hospital in the world to use cultured bone marrow to treat leukaemia. In 2009, Christie Hospital was the first hospital in Europe to conduct a trial of radioimmunotherapy for cancer. This treatment uses antibodies to deliver radiation directly to the cancer site, thereby reducing the damage to healthy tissue.
